Launch-Pharma Technologies, Ltd.
1Patents
1Active
1Granted
39Portfolio score
Filing activity: Sep 25, 2018 → Sep 25, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11046663B2 | Entecavir intermediate, synthetic method thereof and synthetic method for entecavir | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.